Corrigendum to "Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy" [Epilepsy Res. (2023) 191 107112]

In the above article, the affiliations for Prof. Renzo Guerrini should be as follows: Renzo Guerrinid,e dMeyer Children's Hospital IRCCS, Florence, Italy eUniversity of Florence, Florence, Italy The full list of authors and abbreviations should therefore be as follows: Joseph Sullivana, Boudewijn Gunningb, Muhammad Zafarc, Renzo Guerrinid,e, Jozef Geczf, Kristy L. Kolcg, Yufan Zhaoh, Maciej Gasiorh, Alex A. Aimettih, Debopam Samantai aUniversity of California San Francisco Weill Institute for Neurosciences, Benioff Children's Hospital, San Francisco, CA, USA bStichting Epilepsie Instellingen Nederland, Zwolle, the Netherlands cDuke University School of Medicine, Durham, NC, USA dMeyer Children's Hospital IRCCS, Florence, Italy eUniversity of Florence, Florence, Italy fAdelaide Medical School & Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia gUniversity of New South Wales, Sydney, NSW, Australia hMarinus Pharmaceuticals, Inc., Radnor, PA, USA iUniversity of Arkansas for Medical Sciences, Little Rock, AK, USA The authors would like to apologise for any inconvenience caused. DOI of original article: 10.1016/j.eplepsyres.2023.107112